FindTrial
Sign In

Study on the application of clinicopathological characteristics and multimodal imaging in the diagnosis and treatment of differentiated thyroid cancer

Study on the application of clinicopathological characteristics and multimodal imaging in the diagnosis and treatment of differentiated thyroid cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120752
Enrollment
Unknown
Registered
2026-03-19
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

differentiated thyroid cancer

Interventions

Grouping based on postoperative outcomes of thyroid cancer patients or iodine-131 treatment:Case series

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Postoperative pathology confirmed differentiated thyroid cancer (with or without radioactive iodine treatment); 2. Patient underwent enhanced CT, PET/CT or SPECT/CT examination.

Exclusion criteria

Exclusion criteria: 1. Patients with incomplete clinical-pathological data; 2. Absence from follow-up.

Design outcomes

Primary

MeasureTime frame
thyroglobulin;Structural lesion size;—

Countries

China

Contacts

Public ContactYongji Jiang

Shanghai Tenth People's Hospital

jyjdada1997@163.com+86 18752148822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026